Deficiency in thrombopoietin induction after liver surgery is associated with postoperative liver dysfunction.

Thrombopoietin (TPO) has been implicated in the process of liver regeneration and was found to correlate with hepatic function in patients with liver disease. With this investigation we aimed to determine if perioperative TPO levels were associated with postoperative outcome in patients undergoing liver resection.
Perioperative TPO was analyzed prior to liver resection as well as on the first and fifth postoperative day in 46 colorectal cancer patients with liver metastasis (mCRC) as well as 23 hepatocellular carcinoma patients (HCC). Serum markers of liver function within the first postoperative week were used to define liver dysfunction.
While circulating TPO levels significantly increased one day after liver resection in patients without liver cirrhosis (mCRC) (P < 0.001), patients with underlying liver disease (HCC) failed to significantly induce TPO postoperatively. Accordingly, HCC patients had significantly lower TPO levels on POD1 and 5. Similarly, patients with major resections failed to increase circulating TPO levels. Perioperative dynamics of TPO were found to specifically predict liver dysfunction (AUC: 0.893, P < 0.001) after hepatectomy and remained an independent predictor upon multivariate analysis.
We here demonstrate that perioperative TPO dynamics are associated with postoperative LD. Postoperative TPO levels were found to be lowest in high-risk patients (HCC patients undergoing major resection) but showed an independent predictive value. Thus, a dampened TPO increase after liver resection reflects a poor capacity for hepatic recovery and may help to identify patients who require close monitoring or intervention for potential complications.
AuthorsStefanie Haegele, Florian Offensperger, David Pereyra, Elisabeth Lahner, Alice Assinger, Edith Fleischmann, Birgit Gruenberger, Thomas Gruenberger, Christine Brostjan, Patrick Starlinger
JournalPloS one (PLoS One) Vol. 10 Issue 1 Pg. e0116985 ( 2015) ISSN: 1932-6203 [Electronic] United States
PMID25611592 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Thrombopoietin
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Hepatocellular (blood, surgery)
  • Colorectal Neoplasms (blood, surgery)
  • Female
  • Humans
  • Liver (surgery)
  • Liver Failure (blood, etiology)
  • Liver Neoplasms (blood, secondary, surgery)
  • Male
  • Middle Aged
  • Neoplasm Metastasis
  • Postoperative Complications (blood)
  • Thrombopoietin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: